It was found that the expression of CTLA-4 in meningioma tumor cells was consistently elevated in those harboring a mutation that disrupts the PI3K–AKT–mTOR pathway, and anti-CTLA-4 treatment inhibited autophagosome formation (21, 22). The gene discussed is CTLA4; the disease is neoplasm.